ResMed Inc.

General ticker "RSMDF" information:

  • Sector: Health Care
  • Industry: Medical - Instruments & Supplies
  • Capitalization: $33.1B (TTM average)

ResMed Inc. does not follow the US Stock Market performance with the rate: -22.7%.

Estimated limits based on current volatility of 1.5%: low 23.50$, high 24.22$

Factors to consider:

  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2026-11-12, amount 0.07$ (Y1.16%)
  • Total employees count: 11370 (+7.3%) as of 2026
  • US accounted for 63.8% of revenue in the fiscal year ended 2025-06-30
  • Top business risk factors: Inability to compete, Healthcare consolidation and payment reform, Geopolitical risks, Public health crises, Clinical trial success
  • Earnings for 15 months up through Q1 (+1 year) are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-06-30 to 2027-06-30

  • 2025-06-30 to 2026-06-30 estimated range: [19.10$, 28.32$]
  • 2026-06-30 to 2027-06-30 estimated range: [20.86$, 30.61$]

Financial Metrics affecting the RSMDF estimates:

  • Positive: with PPE of 23.0 at the end of fiscal year the price was neutral
  • Positive: Operating cash flow per share per price, % of 54.27 > 24.45
  • Positive: 22.71 < Operating profit margin, % of 32.75
  • Negative: negative Industry operating income (median)
  • Negative: Industry inventory ratio change (median), % of 1.11 > 1.05
  • Positive: Inventory ratio change, % of 0.39 <= 0.44
  • Positive: 68.95 < Shareholder equity ratio, % of 73.01 <= 81.82
  • Negative: Industry earnings per price (median), % of 0 <= 0

Similar symbols

Short-term RSMDF quotes

Long-term RSMDF plot with estimates

Financial data

YTD 2023-06-30 2024-06-30 2025-06-30
Operating Revenue $4,222.99MM $4,685.30MM $5,146.33MM
Operating Expenses $3,091.12MM $3,365.40MM $3,460.96MM
Operating Income $1,131.87MM $1,319.89MM $1,685.36MM
Non-Operating Income $-30.21MM $-55.09MM $-7.80MM
R&D Expense $287.64MM $307.52MM $331.28MM
Income(Loss) $1,101.66MM $1,264.80MM $1,677.57MM
Taxes $204.11MM $243.85MM $276.84MM
Net Income(Loss)* $897.56MM $1,020.95MM $1,400.72MM
Stockholders Equity $4,129.90MM $4,864.04MM $5,967.86MM
Inventory $998.01MM $822.25MM $927.71MM
Assets $6,751.71MM $6,872.39MM $8,174.39MM
Operating Cash Flow $693.30MM $1,401.26MM $1,751.59MM
Capital expenditure $134.00MM $114.86MM $89.86MM
Investing Cash Flow $-1,159.85MM $-269.78MM $-200.04MM
Financing Cash Flow $422.87MM $-1,119.29MM $-606.25MM
Earnings Per Share** $6.12 $6.94 $9.55

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.